Interesting CNP Put And Call Options For December 21st

Investors in CenterPoint Energy, Inc ( CNP) saw new options begin trading today, for the December 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CNP options chain for the new December 21st contracts and identified one put and one call contract of particular interest.

The put contract at the $22.50 strike price has a current bid of 25 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $22.50, but will also collect the premium, putting the cost basis of the shares at $22.25 (before broker commissions). To an investor already interested in purchasing shares of CNP, that could represent an attractive alternative to paying $24.56/share today.

Because the $22.50 strike represents an approximate 8% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 79%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 1.11% return on the cash commitment, or 6.64% annualized — at Stock Options Channel we call this the YieldBoost.

START SLIDESHOW:
Top YieldBoost Puts of the S&P 500 »

Below is a chart showing the trailing twelve month trading history for CenterPoint Energy, Inc, and highlighting in green where the $22.50 strike is located relative to that history:

If you liked this article you might like

Best Companies to Work for in 2017? Here's the Top 10

These Stocks Show Change of Direction

Analysts' Actions -- American Express, Discovery, E-Trade, Xerox and More

CenterPoint Energy Is Breaking Out on the Upside

Credit Suisse Downgrades CenterPoint on Strategic Review Woes